RenBio develops antibody-based therapeutic solutions for the treatment of cancer and inflammatory diseases. RenBio's proprietary MYO technology involves in the development of antibody therapeutic that helps in treating rare diseases, viral infections, autoimmune diseases, and more by using DNA blueprint and antibody factory.

Biotechnology

Health Care

Therapeutics

RenBio

Co-Founders

David D. Ho

Yaoxing Huang

Krystal Ramos

Andy T. Thompson

Robert Miller

Annelyn P. O’Rourke

Marek M. Drozdz

Thanos Papaïoannou

Sheila Ramerman

Rachel A. Liberatore

Meredith Brown-Tuttle

Martin Markowitz

Jim Ackland

RenBio

Org chart

Teams

Similar companies